These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 27670139)

  • 21. Targeting replication stress response using polypurine reverse hoogsteen hairpins directed against WEE1 and CHK1 genes in human cancer cells.
    Aubets E; Noé V; Ciudad CJ
    Biochem Pharmacol; 2020 May; 175():113911. PubMed ID: 32173365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death.
    Del Nagro CJ; Choi J; Xiao Y; Rangell L; Mohan S; Pandita A; Zha J; Jackson PK; O'Brien T
    Cell Cycle; 2014; 13(2):303-14. PubMed ID: 24247149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanding role of WEE1.
    Koh SB
    Cell Signal; 2022 Jun; 94():110310. PubMed ID: 35304285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy.
    McNeely S; Beckmann R; Bence Lin AK
    Pharmacol Ther; 2014 Apr; 142(1):1-10. PubMed ID: 24140082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative Chk1-independent S/M checkpoint in somatic cells that prevents premature mitotic entry.
    Zineldeen DH; Shafik NM; Li SF
    Med Oncol; 2017 Apr; 34(4):70. PubMed ID: 28349497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting replicative stress in gynecological cancers as a therapeutic strategy.
    Ngoi NY; Sundararajan V; Tan DS
    Int J Gynecol Cancer; 2020 Aug; 30(8):1224-1238. PubMed ID: 32571890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods to study cancer therapeutic drugs that target cell cycle checkpoints.
    Dai Y; Grant S
    Methods Mol Biol; 2011; 782():257-304. PubMed ID: 21870298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
    Ghelli Luserna Di Rorà A; Ghetti M; Ledda L; Ferrari A; Bocconcelli M; Padella A; Napolitano R; Fontana MC; Liverani C; Imbrogno E; Bochicchio MT; Paganelli M; Robustelli V; Sanogo S; Cerchione C; Fumagalli M; Rondoni M; Imovilli A; Musuraca G; Martinelli G; Simonetti G
    Cell Biol Toxicol; 2023 Jun; 39(3):795-811. PubMed ID: 34519926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis.
    Wang Y; Decker SJ; Sebolt-Leopold J
    Cancer Biol Ther; 2004 Mar; 3(3):305-13. PubMed ID: 14726685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor.
    Massey AJ; Borgognoni J; Bentley C; Foloppe N; Fiumana A; Walmsley L
    PLoS One; 2010 Oct; 5(10):e13123. PubMed ID: 20976184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage checkpoint kinases in cancer.
    Smith HL; Southgate H; Tweddle DA; Curtin NJ
    Expert Rev Mol Med; 2020 Jun; 22():e2. PubMed ID: 32508294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitotic functions of poly(ADP-ribose) polymerases.
    Slade D
    Biochem Pharmacol; 2019 Sep; 167():33-43. PubMed ID: 30910692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chk1-Mad2 interaction: a crosslink between the DNA damage checkpoint and the mitotic spindle checkpoint.
    Chilà R; Celenza C; Lupi M; Damia G; Carrassa L
    Cell Cycle; 2013 Apr; 12(7):1083-90. PubMed ID: 23454898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHK1 monitors spindle assembly checkpoint and DNA damage repair during the first cleavage of mouse early embryos.
    Ju JQ; Li XH; Pan MH; Xu Y; Sun MH; Xu Y; Sun SC
    Cell Prolif; 2020 Oct; 53(10):e12895. PubMed ID: 32914523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD 98059 prevents establishment of the spindle assembly checkpoint and inhibits the G2-M transition in meiotic but not mitotic cell cycles in Xenopus.
    Cross DA; Smythe C
    Exp Cell Res; 1998 May; 241(1):12-22. PubMed ID: 9633509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unleashing Chk1 in cancer therapy.
    Carrassa L; Damia G
    Cell Cycle; 2011 Jul; 10(13):2121-8. PubMed ID: 21610326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition.
    Haynes B; Murai J; Lee JM
    Cancer Treat Rev; 2018 Dec; 71():1-7. PubMed ID: 30269007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spindle assembly checkpoint.
    Lara-Gonzalez P; Westhorpe FG; Taylor SS
    Curr Biol; 2012 Nov; 22(22):R966-80. PubMed ID: 23174302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centrosomal Che-1 protein is involved in the regulation of mitosis and DNA damage response by mediating pericentrin (PCNT)-dependent Chk1 protein localization.
    Sorino C; Bruno T; Desantis A; Di Certo MG; Iezzi S; De Nicola F; Catena V; Floridi A; Chessa L; Passananti C; Cundari E; Fanciulli M
    J Biol Chem; 2013 Aug; 288(32):23348-57. PubMed ID: 23798705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chk1: a double agent in cell cycle checkpoints.
    Yu H
    Dev Cell; 2007 Feb; 12(2):167-8. PubMed ID: 17276330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.